Dr Usmani on the Optimal Role for Cilta-Cel in Relapsed/Refr

Saad Z. Usmani, MD, MBA, FACP, FASCO, discusses the optimal role for ciltacabtagene autoleucel in relapsed/refractory multiple myeloma.

Related Keywords

, Saadz Usmani , Memorial Sloan Kettering Cancer Center , Myeloma Service , D , Nba , Naacp , Pasco , Fda Approval Of Cilta Cel , Relapsed Refractory Multiple Myeloma ,